Humasis, Top Search Ranking... Stock Price -3.25%
Humasis is trading at 13,400 KRW as of 2:30 PM on the 14th, down 3.25% from the previous day. This represents a 222.12% increase compared to June 16. Humasis is known as an in vitro diagnostic device company.
Over the past five days, individual investors have net purchased 105,518 shares, while foreigners and institutions have net sold 57,501 shares and 34,310 shares, respectively.
On July 13, Humasis became a market issue with the headline "Concerns over COVID-19 resurgence... surges 16%".
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
Hot Picks Today
"Do We Need to Panic Buy Again?" War Drives 30% Price Surge... Even the Bedroom Feels the Impact
- "Is a 10,000 KOSPI Breakthrough Possible?" Target Index Raised by 40%... Securities Firms Release Outlook [Weekend Money]
- There Is a Distinct Age When Physical Abilities Decline Rapidly... From What Age Do Strength and Endurance Drop?
- "Anyone Who Visited the Room Salon, Come Forward"… Gangnam Police Station Launches Full Staff Investigation After New Scandal
- "Contact Me First If Houses Are Built": Wealthy Clients Eyeing... Will Ultra-High-End Residences Worth 20 Billion Won Be Developed? [Real Estate AtoZ]
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
